Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

OBJECTIVE: To determine whether rheumatoid factor (RF), anti-cyclic citrullinated peptide (CCP) antibodies, or carriage of shared epitope (SE) and PTPN22 genetic susceptibility variants predict response to therapy in patients with rheumatoid arthritis (RA) treated with anti-tumour necrosis factor (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Potter, C, Hyrich, K L, Tracey, A, Lunt, M, Plant, D, Symmons, D P M, Thomson, W, Worthington, J, Emery, P, Morgan, A W, Wilson, A G, Isaacs, J, Barton, A
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2009
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596303/
https://www.ncbi.nlm.nih.gov/pubmed/18375541
http://dx.doi.org/10.1136/ard.2007.084715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596303/
https://www.ncbi.nlm.nih.gov/pubmed/18375541
http://dx.doi.org/10.1136/ard.2007.084715

Ejemplares similares